Chemistry:CUMYL-CH-MEGACLONE

From HandWiki
Short description: Chemical compound
CUMYL-CH-MEGACLONE
CUMYL-CH-MEGACLONE structure.png
Legal status
Legal status
Identifiers
PubChem CID
ChemSpider
UNII
Chemical and physical data
FormulaC27H30N2O
Molar mass398.54 g·mol−1
3D model (JSmol)

CUMYL-CH-MEGACLONE (CUMYL-CHMGACLONE, SGT-270) is a gamma-carboline based synthetic cannabinoid receptor agonist that has been sold as a designer drug, first being identified in Hungary in December 2018.[1][2][3]

See also

References

  1. "Adding more "spice" to the pot: A review of the chemistry and pharmacology of newly emerging heterocyclic synthetic cannabinoid receptor agonists". Drug Testing and Analysis 12 (3): 297–315. March 2020. doi:10.1002/dta.2752. PMID 31854124. 
  2. "The Novel Psychoactive Substance Cumyl-CH-MEGACLONE: Human Phase-I Metabolism, Basic Pharmacological Characterization, and Comparison to Other Synthetic Cannabinoid Receptor Agonists with a γ-Carboline-1-one Core.". Journal of Analytical Toxicology 45 (3): 277–290. June 2020. doi:10.1093/jat/bkaa065. PMID 32514544. 
  3. "Clinical symptoms and blood concentration of new psychoactive substances (NPS) in intoxicated and hospitalized patients in the Budapest region of Hungary (2018-19)". Clinical Toxicology (Philadelphia, Pa.) 60 (1): 18–24. June 2021. doi:10.1080/15563650.2021.1928162. PMID 34080493.